Dirk may be right about the board, but it is presumptuous to...

Dirk may be right about the board, but it is presumptuous to connect leadership change with clinical trial results. Which floors me at how much people like to hear themselves talk and have so much influence, like KSS, but can't keep their logic straight. The results of TT-034 on viral load are unknown still. But the science continues to point towards a positive outcome. The company more than likely is not happy with the leadership decisions (duh), and want a more US based leadership and presence. All that can happen with positive results still on their way.

Until there is a direct report on viral load, any statements like Dirk's or anyone else, including mine, is just supposition.